Gp. | Number studied | Number positive | |||
---|---|---|---|---|---|
IgG | IgM | IgA | |||
I | HIV+Crypto+ | 11 | 11 (100) | 2 (18.2) | 7 (63.6) |
II | HIV+Crypto- | 20 | Nil | Nil | 4 (20) |
III | HIV-Crypto+ | 10 | 10 (100) | 2 (20) | 5 (50) |
IIIa | HIV-Crypto+ | 4 | 4 (100) | 1 (25) | 1 (25) |
IIIb | HIV-Crypto+ | 6 | 6 (100) | 1 (16.7) | 4 (66.7) |
IV | HIV-Crypto- | 20 | Nil | Nil | 2 (10) |
V | Other parasitic diseases | 25 | 3 (12) | 2 (8) | 2 (8) |
Sensitivity (%) | 100 | 19 | 57.1 | ||
Specificity (%) | 95.4 | 97 | 87.7 | ||
I vs II | <0.0001 | NS | <0.05 | ||
I vs IV | <0.0001 | NS | <0.01 | ||
P | I vs V | <0.0001 | NS | <0.01 | |
II vs III | <0.0001 | NS | <0.05 | ||
III vs IV | <0.0001 | NS | <0.05 | ||
III vs V | <0.0001 | NS | <0.05 |